NASDAQ : EAC

Edify Acquisition Corp. — News

$10.65 USD

$0.01 (0.09%)

Volume
46.7K
Average Volume
11.1K
Market Capitalization
$84.03M
P/E Ratio
33.28
Dividend Yield
0.00%
Price Target
Year High
$11.40
Year Low
$10.23
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.13
Source Headline
Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significan

gurufocus.com - 2026-07-27 08:00:00

Newmont's Red Chris Block Cave Project Receives Major Regulatory Approvals

Newmont Corporation (NYSE: NEM, ASX: NEM, PNGX: NEM) (“Newmont”) welcomes the Province of British Columbia's approval of key regulatory authorizations for

gurufocus.com - 2026-06-19 13:00:00

KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema

[url="]KalVista Pharmaceuticals[/url], Inc. (Nasdaq: KALV) today announced new data highlighting the burden of injectable on-demand treatment in children aged

gurufocus.com - 2026-05-28 08:00:00

Get EAC Insider Trade Alerts

EAC Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

EAC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2015-08-07 Canaccord Genuity Maintain Hold Hold
2015-08-06 Canaccord Genuity Maintain Hold Hold
2015-06-19 Imperial Capital Upgrade In Line Outperform
2015-06-18 Imperial Capital Upgrade In Line Outperform
2015-05-12 Canaccord Genuity Maintain Hold Hold
2015-05-11 Canaccord Genuity Maintain Hold Hold